The global neurovascular embolization devices market is anticipated to grow at a considerable CAGR of 6.3% during the forecast period. Arteriovenous malformations are a developmental anomaly of the vascular system, consisting of tangles of poorly formed blood vessels in which the feeding arteries are directly connected to a venous drainage network without any interposed capillary system. AVMs can occur anywhere in the body, however, brain AVMs are of special concern because of the inherent high risk of bleeding of the abnormal blood vessels that cause neurological damage. According to the National Institutes of Health, approximately 41.0% to 79.0% present with intracranial hemorrhage. AVMs are the second most common cause of intracranial bleed after cerebral aneurysms, responsible for 10.0% of all cases of subarachnoid hemorrhage. The incidence in the US is 1.3 per 100,000 persons, although the actual prevalence rate is higher due to clinically silent disease, as only 12.0% of AVMs are estimated to become symptomatic. The mortality rate is 10.0%-15.0% of patients who have a hemorrhage, and morbidity varies from approximately 30.0%-50.0%. AVMs tend to be clinically asymptomatic in 15.0% of cases until the presenting event occurs.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/neurovascular-embolization-devices-market
Furthermore, the increasing number of partnerships and collaborations to develop a product to cater to the demand for neurovascular embolization devices is accelerating the market growth. For instance, in December 2021, Wallaby Medical, a medical device company focused on developing and commercializing medical device products for treating stroke partnered with Japan Lifeline Co., Ltd., a publicly-listed medical device manufacturer and distributor with 48 sales offices across Japan, to bring Wallaby’s Japan PMDA approved Avenir® Coil System to the Japanese market. Avenir® is used in the intravascular embolization of intracranial aneurysms and other neurovascular malformations such as arteriovenous malformations and arteriovenous fistulas, as well as arterial and venous embolization of peripheral blood vessels.
Market Coverage
- The market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2023-2030
- Segment Covered-
o By Product
o By End-Use
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape- including B. Braun Melsungen AG, Cerenovus Inc., Medtronic plc, Stryker Corp., and others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Neurovascular Embolization Devices Market Report Segment
By Product
- Embolic Coils
- Flow Diversion Devices
By End-Use
- Hospitals
- Specialty Clinics
A full report of Neurovascular Embolization Devices Market available @ https://www.omrglobal.com/industry-reports/neurovascular-embolization-devices-market
Global Neurovascular Embolization Devices Market Report Segment by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Rest of the World
- Latin America
- Middle East & Africa
Company Profiles
- Acandis GmbH
- Balt Extrusion SA
- Boston Scientific Corp.
- DePuy Synthes (Johnson & Johnson Services, Inc.)
- Integra Lifesciences Holdings Corp.
- MicroVention Inc.
- Penumbra Inc.
- Phenox GmbH
- Resonetics LLC
- Spartan Micro, Inc.
- Terumo Medical Corp.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
